Biotech Coverage

Biotech names covered by Thomas Bouman. Each one opens with company coverage: what it does, the pipeline, and the bull and bear case, revised over time as things change. It then stays current through short notes around FDA decisions, readouts and results. Ratings and price targets are dated and never rewritten. Not financial advice.